Stock Information
Enliven Therapeutics Inc (ELVN)
Ticker Symbol: ELVN
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $2,154.61 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -1.6633
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -21.04%
Latest News
-
Enliven Therapeutics, Inc. (ELVN) Presents at European Hematology Association (EHA) 2026 Congress - Slideshow
Mon, Jun 15, 2026 7:04 PM
-
Enliven Therapeutics, Inc. (ELVN) Discusses Updated Phase 1 ENABLE Trial Data for ELVN-001 in Previously Treated Chronic Myeloid Leukemia - Slideshow
Fri, Jun 12, 2026 1:31 AM
Key Financials
Financial data not available
